Formulary Search Results for: TEDUGLUTIDE
1.5.6 Medicines for Short Bowel Syndrome - View Category
Restricted to specialist use in adults with short bowel syndrome (SBS) who are stable following a period of intestinal adaptation after surgery in accordance with locally agreed guidance notes as outlined in the prescribing notes below.
- Only for prescribing by the GRI Intestinal Failure team for patients with short bowel syndrome after all other treatment has been optimised
- Candidates should have stable Parenteral Nutrition (PN)/ intravenous (IV) fluid prescriptions for at least two years before treatment is initiated
- A reduction in requirement for parenteral nutrition will measure the success of treatment and support ongoing prescribing